Shanghai, China

Liqing Kang


 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: The Innovative Contributions of Liqing Kang

Introduction

Liqing Kang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedicine, particularly in the development of CAR-T therapies. With a total of six patents to his name, Kang's work focuses on innovative methods to enhance cancer treatment.

Latest Patents

Kang's latest patents include groundbreaking technologies such as siRNA knocking down human PD-1 and recombinant expression CAR-T vectors. These inventions provide a human PD-1 knockdown siRNA, a recombinant expression CAR-T vector, and their respective preparation methods and applications. The PD-1 knockdown siRNA expression cassette can be utilized in CAR-T therapy for multiple myeloma, effectively eliminating or alleviating tumor immune escape mechanisms. Additionally, his work addresses the suppression of immune escape mechanisms in CAR-T therapies for various tumors, including pancreatic cancer and brain glioma.

Another notable patent involves an OCTS technology-based CAR-T therapeutic vector designed for treating pancreatic cancer and malignant mesothelioma. This invention comprises a lentiviral skeleton plasmid, a human EF1α promoter, and an OCTS chimeric receptor structural domain. The structural domain includes various components such as single-chain antibodies and chimeric receptor domains, which work together to enhance the efficacy of CAR-T therapies.

Career Highlights

Liqing Kang is currently associated with Shanghai Unicar-therapy Bio-medicine Technology Co., Ltd. His role in this company allows him to further his research and development efforts in the field of cancer therapies. His innovative approach and dedication to improving treatment options have positioned him as a key figure in biomedicine.

Collaborations

Kang collaborates with talented individuals such as Lei Yu and Zhou Yu. Their combined expertise contributes to the advancement of their projects and the overall success of their research initiatives.

Conclusion

Liqing Kang's contributions to the field of biomedicine through his innovative patents and collaborative efforts highlight his commitment to advancing cancer treatment. His work continues to pave the way for new therapeutic options that can significantly impact patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…